Navigation Links
Neogen's Rapid Test for Salmonella enteritidis Receives AOAC Approval
Date:11/8/2010

LANSING, Mich., Nov. 8, 2010 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) today announced that its rapid test for Salmonella enteritidis (SE) has received approval from AOAC International.

Neogen's newly approved test kit, Reveal® for Salmonella enteritidis, provides the egg industry with a quick, accurate and easy method of detecting this pathogen, as the U.S. Food and Drug Administration implements new SE-regulations. The AOAC's process validated the accuracy of the Reveal for SE system when testing either environmental or egg samples.

"The AOAC's approval further validates our test as an invaluable tool to egg producers, as they comply with the FDA's new regulations, and seek to further reduce the likelihood of SE-contaminated eggs reaching consumers," said Ed Bradley, Neogen's vice president of Food Safety. "Until our introduction of an effective rapid test for SE, the industry had to wait up to 7 days for an outside laboratory's test results. Reveal for SE enables the industry to get results within 48 hours — and provides the rapid, accurate answer they need to manage their flocks and egg production."  

Reveal for SE is the only rapid test available for SE that follows the FDA's sample enrichment protocol and has received AOAC approval. Neogen, in cooperation with USDA scientists, began the development of this test in 2000.

"Using a rapid test for SE that uses the same sample enrichment protocol as the FDA not only allows analysts to quickly screen out negative test results, but also is compatible with the FDA confirmation process by using the same enriched samples," said Bradley. "Especially now, with the heightened concern for contaminated eggs, time is of the essence."  

The foodborne illness caused by SE is generally due to eating raw, incompletely cooked, or recontaminated eggs. Ingestion of SE-contaminated poultry meat is the second leading cause of this illness.

Neogen's comprehensive line of products it offers to the poultry industry also includes a full line of agricultural cleaners and disinfectants, and rodenticides, to stop the spread of infectious disease from animal to animal, and from production facilities to the consumer.

Neogen Corporation (Nasdaq: NEOG) develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases, and sanitation concerns, and dehydrated culture media. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry
2. Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts
3. Rapid Increase in the Number of Worldwide Nanotechnology Degree Programs
4. Celsis Rapid Detections Updated Drug Master Files (DMFs) Accepted by FDA
5. An optical traffic cop for rapid communication
6. Maine Medical Center Chooses Business Intelligence Solution from Rapid Insight Inc.
7. RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™
8. Wound Management Technologies, Inc. Rapidly Expands Its International Presence
9. Study: Era of Rapid Growth in Biomedical Research Over
10. Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM(R) Kit is a Reliable, Rapid Method for Extracting DNA From Saliva
11. Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Savannah River ... technologies and selected NewTechBio,s NT-MAX Lake & ... based beneficial bacteria, in conjunction with Hexa Armor/ ... deficiencies with National Pollutant Discharge Elimination System requirements. ... experienced a steady history of elevated pH levels, ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
(Date:12/7/2016)... EDMONTON , Dec. 7, 2016 /PRNewswire/ - ... the development and commercialization of immunotherapeutic products for ... has entered into an Antibody Manufacturing Development Program ... , USA) for its oregovomab antibody product. ... its Phase IIb clinical study in ovarian cancer ...
(Date:12/7/2016)... -- The report "Acrylic Processing Aid Market by Polymer Type (PVC), Fabrication Process ... Global Forecast to 2026", published by MarketsandMarkets, the global market size was USD ... 2026, registering an of CAGR of 6.2% between 2016 and 2026. ... ... MarketsandMarkets Logo , ...
Breaking Biology Technology:
(Date:12/6/2016)... Dec. 6, 2016 Valencell , the leading ... has seen a third consecutive year of triple digit ... in 2016 with a 360 percent increase in companies ... increase was driven by sales of its wrist and ... in its technology for hearables for fitness and healthcare ...
(Date:12/2/2016)... PUNE, India , December 1, 2016 /PRNewswire/ ... Market by Authentication type (Fingerprint, Voice), Future Technology (Iris ... Vehicle), and Region - Global Forecast to 2021", ... be USD 442.7 Million in 2016, and is ... 2021, at a CAGR of 14.06%. ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...
Breaking Biology News(10 mins):